HHS could be renamed under Trump reorganization plan

A plan set to be released by the Trump administration in the coming weeks would change both the name and the responsibilities of HHS, according to Politico.

The rumored White House Office of Management and Budget plan would move more of the federal government’s safety net programs, like food stamps, into HHS. This would fall in line with existing initiatives favored by the Trump administration on the state level to align standards for food stamps (formally know as the Supplemental Nutrition Assistance Program, or SNAP) with Medicaid when it comes to requirements for beneficiaries to work.

SNAP is currently administered by the U.S. Department of Agriculture (USDA) with its $70 billion making up the vast majority of the department’s annual budget. The move has been favored by conservative groups like the Heritage Foundation as part of a consolidation of all USDA nutrition programs into HHS.

“By moving this welfare function to HHS, the USDA will be better able to work on agricultural issues impacting all Americans,” the group wrote in its 2017 federal reorganization proposal.

With these added responsibilities, HHS would be renamed to “emphasize programs that provide assistance to low-income Americans,” Politico reported. This could mean the word “welfare” is added back to the name. Before being reorganized into HHS in 1980, many of the same duties were under jurisdiction of the Department of Health, Education and Welfare.  

Read more at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.